References
1.
Woodring JH, Ciporkin G, Lee C, Worm B, Woolley S: Pulmonary cryptococcosis. Semin Roentgenol 1996;30:67–75.
2.
Huchon GJ, Roche N: Fungal and parasitic pneumonia; in Albert R, Spiro S, Jett J (eds): Comprehensive Respiratory Medicine. St Louis, Mosby, 1999, p 23.1
3.
Young EJ, Hirsh DD, Fainstein V, Williams TW: Pleural effusions due to Cryptococcus neoformans: A review of the literature and a report of two cases with cryptococcal determinations. Am Rev Respir Dis 1980;121:743–747.
4.
Wu TT, Wang HC, Yang PC, Kuo SH, Luh KT: Pulmonary cryptococcosis: Manifestations in the era of acquired immunodeficiency syndrome. J Formosan Med Assoc 1999;98:621–626.
5.
Emmons WW 3rd, Luchsinger S, Miller L. Progressive pulmonary cryptococcosis in a patient who is immunocompetent. South Med J 1995;88:657–660.
6.
Vilchez RA, Linden P, Lacomis J, Costello P, Fung J, Kusne S: Acute respiratory failure associated with pulmonary cryptococcosis in a non-AIDS patient. Chest 2001;119:1865–1869.
7.
Schubert S, Lebeau A, Zell R, Goebel F: Cavitary cryptococcoma of the lungs and meningitis by Cryptococcus neoformans in a patient with AIDS. Eur J Med Res 1997;2:173–176.
8.
Lacoamis JM, Costello P, Vilchez R, Kusne S: The radiology of pulmonary cryptococcosis in a tertiary medical center. J Thorac Imaging 2001;16:139–148.
9.
Pantongrag-Brown L. Case of the season. Semin Roentgenol 1991;26:101–102.
10.
Bhaduri A, Amonkar G, Amonkar P: Asymptomatic pulmonary cryptococcosis diagnosed on fine needle cytology. A case report. Acta Cytol 2000;44:1111–1113.
11.
Kuo TH, Hsu WH, Chiang CD, Huang CM, Chen CY, Chang MC: Ultrasound-guided fin needle aspiration biopsy in the diagnosis of pulmonary cryptococcosis. J Formosan Med Assoc 1998;97:197–203.
12.
Liaw Y-S, Yang P-C, Yu C-J, Chang D-B, Wang H-J, Lee L-N, Kho S-H, Luh K-T: Direct determination of cryptococcal antigen in transthorasic needle aspirate for the diagnosis of pulmonary cryptococcoma. J Clin Microbiol 1995;33:1588–1591.
13.
Aberg JA, Mundy LM, Powderly WG: Pulmonary cryptococcosis in patients without HIV infection. Chest 1999;115:734–740.
14.
Nunez M, Peacock JE, Chin R: Pulmonary crytococcosis in the immunocompetent host. Therapy with oral Fluconazole: A report of four cases and review of the literature. Chest 2000;118:527–534.
15.
Yamamoto Y, Maesaki S, Kakeya H, Yanagihara K, Ohno H, Ogawa K, Hirakata Y, Tomono K, Tashiro T, Kohno S: Combination therapy with fluconazole and flucytosine for pulmonary cryptococcosis. Chemotherapy 1997;43:436–441.
16.
Yamaguchi H, Ikemoto H, Watanabe K, Ito A, Hara K, Kohno S: Fluconazole monotherapy for cryptococcosis in non-AIDS patients. Eur J Clin Microbiol Infect Dis 1996;15:787–792.
© 2004 S. Karger AG, Basel
2004
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the...
© 2004 S. Karger AG, Basel
2004
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
